PCR64 Patient Satisfaction With 6-Monthly Versus 3-Monthly Paliperidone Palmitate Long-Acting Injectable for Schizophrenia Treatment: Results From a Phase-3, Randomised, Noninferiority Study
- Resource Type
- Abstract
- Source
- In
Value in Health December 2022 25(12) Supplement:S402-S402 - Subject
- Language
- ISSN
- 1098-3015